|
|
Volumn 15, Issue 5, 2016, Pages 299-
|
|
EMA greenlights second gene therapy
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADENOSINE DEAMINASE;
AGAMMAGLOBULINEMIA;
DEFICIENCY;
DRUG APPROVAL;
EUROPE;
GENE THERAPY;
GENETICS;
HUMAN;
LEGISLATION AND JURISPRUDENCE;
PROCEDURES;
SEVERE COMBINED IMMUNODEFICIENCY;
ADENOSINE DEAMINASE;
AGAMMAGLOBULINEMIA;
DRUG APPROVAL;
EUROPE;
GENETIC THERAPY;
HUMANS;
SEVERE COMBINED IMMUNODEFICIENCY;
|
|
EID: 85023765920
PISSN: None
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd.2016.93 Document Type: Article |
|
Times cited : (5)
|
|
References (0)
|